Security key
00808Y406
Aethlon Medical, Inc. - Common Stock, $0.001 par value per share (AEMD)
CUSIP: 00808Y406
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock, $0.001 par value per share
- Total 13F shares
- 405,570
- Total 13F value
- $186,762
- Share change
- +224,264
- SEC-reported price per share
- $0.47
- Number of holders
- 18
- Value change
- +$101,602
- Number of buys
- 11
- Number of sells
- 7
- Shares outstanding
- 1,651,503
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
18
Top holders
10
AEMD full security history
Ownership snapshot
Full 13F holder table
AETHLON MEDICAL INC SEC filings
AETHLON MEDICAL INC company facts
Broader feeds
Ownership snapshot
Top reported holders of AEMD - Aethlon Medical, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Sabrina Martucci Johnson
Disclosed value leader
Sabrina Martucci Johnson
Comparable rows
0/15
Latest evidence
30 Jun 2024
3/4/5
13F
Highest disclosed value: $73,676
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Sabrina Martucci Johnson has the largest disclosed position value at $73.7K.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Sabrina Martucci Johnson's linked filing trail.
Disclosed position value
Top 5
Sabrina Martucci Johnson
$73.7K
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$18.3K
TWO SIGMA SECURITIES, LLC
$17.2K
JANE STREET GROUP, LLC
$13.2K
VANGUARD GROUP INC
$10.6K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Sabrina Martucci Johnson |
3/4/5
Director
|
—
denominator unverified
|
$73,676
33,642 shares
|
— | 31 Mar 2022 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
—
denominator unverified
|
$18,278
36,652 shares
|
— | 30 Jun 2024 |
| TWO SIGMA SECURITIES, LLC |
13F
Company
|
—
denominator unverified
|
$17,227
34,544 shares
|
— | 30 Jun 2024 |
| JANE STREET GROUP, LLC |
13F
Company
|
—
denominator unverified
|
$13,170
26,408 shares
|
— | 30 Jun 2024 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$10,584
21,224 shares
|
— | 30 Jun 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$10,110
20,274 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
18
Shares
405,570
Rows available
18
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
18
Q3 2024 holders
18
Holder diff
0
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|